Thesis pillars
- Steady Revenue Growth↑Improving
- Perfect Earnings Beat Streak↑Improving
- Strong Financial Health Score→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Oct 24, 2026
Materialise NV (MTLS) Stock Analysis
Oversold Bounce setup
Technology · Software - Application
Hold if already holding. Not a fresh buy at $6.78, but acceptable to hold if already in. Reason: Market cap $388M below $400M minimum.
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The... Read more
Hold if already holding. Not a fresh buy at $6.78, but acceptable to hold if already in. Reason: Market cap $388M below $400M minimum. Chart setup: Oversold RSI 22, near Bollinger lower, volume surge. Market cap $388M below $400M minimum. Not in investable universe. Score 5.7/10, moderate confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-10-29Recent Developments — Materialise NV
Latest news
- NEWS Revenue rose 2.1% at Materialise (MTLS), but Q3 profit fell. - Stock Titan — Stock Titan positive
- NEWS Materialise: Q3 Earnings Snapshot - Yahoo Finance — Yahoo Finance neutral
- NEWS Materialise Q3 Earnings Call Highlights - Yahoo Finance — Yahoo Finance neutral
- NEWS Materialise Stock Falls 22% After Earnings Miss - StocksToTrade — StocksToTrade negative
- NEWS Materialise Q3 2026 Earnings Call Transcript - Benzinga — Benzinga neutral
Generated 2026-10-29T11:08:51Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
10 dimensions · all in-band
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $6.78, but acceptable to hold if already in. Reason: Market cap $388M below $400M minimum. Chart setup: Oversold RSI 22, near Bollinger lower, volume surge. Market cap $388M below $400M minimum. Not in investable universe. Analyst target $7.48 (+10.3%), stop $6.31 (−7.4%), A.R:R 0.9:1. Score 5.7/10, moderate confidence.
Analyst target: $7.48 (+10.3% upside). Analyst target $7.48 (+10.3%), stop $6.31 (−7.4%), A.R:R 0.9:1. Stop-loss: $6.31.
Market cap $388M below $400M minimum.
Materialise NV trades at a P/E of 24.2 (forward 26.2). TrendMatrix value score: 6.4/10. Verdict: Hold.
9 analysts cover MTLS with a consensus score of 4.1/5. Average price target: $9.
What does Materialise NV do?Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas,...
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.